Dr. Reckamp on Molecular Testing in Lung Cancer

Karen Reckamp, MD, MS, medical oncologist, City of Hope, discusses the role of molecular testing for patients with lung cancer.

Karen Reckamp, MD, MS, medical oncologist, City of Hope, discusses the role of molecular testing for patients with lung cancer.

Molecular testing is important because there are genes that have specific targeted drugs available, explains Reckamp.

According to Reckamp, moving towards next-generation sequencing is important so that there is more access for more patients but it needs to be made affordable.

Related Videos
Brian A. Van Tine, MD, PhD
Jason Luke, MD, FACP
Katherine B. Peters, MD, PhD
Yasushi Goto, MD
Prithviraj Bose, MD, associate professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Jun Ma, MD
Hussein A. Tawbi, MD, PhD
Katsumori Asai, MD, PhD
Bernard Doger de Spéville, MD, PhD
Related Content